Skip to main content
Clinical Trials/KCT0006592
KCT0006592
Not yet recruiting
未知

A multicenter randomized controlled study to evaluate the efficacy of a 24-week multidomain intervention via face-to-face and video communication platforms in mild cognitive impairment

Inha University Hospital0 sites300 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Mental and behavioural disorders
Sponsor
Inha University Hospital
Enrollment
300
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 60 to 79 years of age
  • \- Having at least one modifiable dementia risk factor
  • \- Complaints of cognitive decline by a participant or informant
  • \- A performance score that is lower than 1\.0 standard deviations below the age\-, and education\-adjusted normative means for one or more of
  • the delayed recall, naming, visuoconstruction, attention, and executive function tests
  • \- MMSE Z score \= \- 1\.5
  • \- Independent activities of daily living
  • \- Being able to use the tablet PC through education, or having a person who can help a participant use the tablet PC.
  • \- Having a reliable informant who could provide investigators with the requested information
  • \- Provide written informed consent

Exclusion Criteria

  • \- Major psychiatric illness such as major depressive disorders
  • \- Dementia
  • \- Other neurodegenerative disease (e.g., Parkinson’s disease)
  • \- Malignancy within 5 years
  • \- Cardiac stent or revascularization within 1 year
  • \- Serious or unstable symptomatic cardiovascular disease
  • \- Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease
  • \- Severe loss of vision, hearing, or communicative disability
  • \- Any conditions preventing cooperation as judged by the study physician
  • \- Significant laboratory abnormality that may result in cognitive impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials